Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CD95 LIGAND' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 225 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Steinbach, JP; Supra, P; Huang, HJS; Cavenee, WK; Weller, M
      CD95-mediated apoptosis of human glioma cells: Modulation by epidermal growth factor receptor activity

      BRAIN PATHOLOGY
    2. Treon, SP; Mitsiades, C; Mitsiades, N; Young, G; Doss, D; Schlossman, R; Anderson, KC
      Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies

      JOURNAL OF IMMUNOTHERAPY
    3. Martin-Villalba, A; Hahne, M; Kleber, S; Vogel, J; Falk, W; Schenkel, J; Krammer, PH
      Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke

      CELL DEATH AND DIFFERENTIATION
    4. Wagenknecht, B; Roth, W; Gulbins, E; Wolburg, H; Weller, M
      C2-ceramide signaling in glioma cells: synergistic enhancement of CD95-mediated, caspase-dependent apoptosis

      CELL DEATH AND DIFFERENTIATION
    5. Strater, J; Walczak, H; Hasel, C; Melzner, I; Leithauser, F; Moller, P
      CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies

      CELL DEATH AND DIFFERENTIATION
    6. Ni, X; Hazarika, P; Zhang, CL; Tapur, R; Duvic, M
      Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+cytotoxic T lymphocytes in mycosis fungoides: A potential mechanism of tumor immune escape?

      CLINICAL CANCER RESEARCH
    7. Yeh, YA; Wang, JW; Fan, CY; MacLeod, SL; Fan, K
      Expression of Fas ligand in metastatic prostatic carcinoma: Suggestive of possible clonal expansion of subpopulation with metastatic potential

      DIAGNOSTIC MOLECULAR PATHOLOGY
    8. Gerhardt, E; Kugler, S; Leist, M; Beier, C; Berliocchi, L; Volbracht, C; Weller, M; Bahr, M; Nicotera, P; Schulz, JB
      Cascade of caspase activation in potassium-deprived cerebellar granule neurons: Targets for treatment with peptide and protein inhibitors of apoptosis

      MOLECULAR AND CELLULAR NEUROSCIENCE
    9. Hsu, PN; Lin, HH; Tu, CF; Chen, NJ; Wu, KM; Tsai, HF; Hsieh, SL
      Expression of human Fas ligand on mouse beta islet cells does not induce insulitis but is insufficient to confer immune privilege for islet grafts

      JOURNAL OF BIOMEDICAL SCIENCE
    10. Rohn, TA; Wagenknecht, B; Roth, W; Naumann, U; Gulbins, E; Krammer, PH; Walczak, H; Weller, M
      CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release

      ONCOGENE
    11. Santourlidis, S; Warskulat, U; Florl, AR; Maas, S; Pulte, T; Fischer, J; Muller, W; Schulz, WA
      Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo-1) gene promoter at rel/nuclear factor kappa B sites in prostatic carcinoma

      MOLECULAR CARCINOGENESIS
    12. Jackle, T; Hasel, C; Melzner, I; Bruderlein, S; Jehle, PM; Moller, P
      Sustained hyposmotic stress induces cell death: apoptosis by defeat

      AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
    13. Biswas, RS; Cha, HJ; Hardwick, JM; Srivastava, RK
      Inhibition of drug-induced Fas ligand transcription and apoptosis by Bcl-X-L

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    14. Eneslatt, K; Rantapaa-Dahlqvist, S; Uddhammar, A; Sundqvist, KG
      The regulation of FasL expression - A distinguishing feature between monocytes and T lymphocytes/NK cells with possible implications for SLE

      JOURNAL OF CLINICAL IMMUNOLOGY
    15. Ma, YH; Fei, J; Hu, JH; Zhou, XG; Xia, GH; Guo, LH
      Transgenic mice ubiquitously expressing human Fas ligand develop a slight form of graft-versus-host-like disease

      ACTA PHARMACOLOGICA SINICA
    16. Koyama, S; Koike, N; Adachi, S
      Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    17. Aktas, O; Waiczies, S; Grieger, U; Wendling, U; Zschenderlein, R; Zipp, F
      Polyspecific immunoglobulins (IVIg) suppress proliferation of human (auto)antigen-specific T cells without inducing apoptosis

      JOURNAL OF NEUROIMMUNOLOGY
    18. Verbeke, CS; Wenthe, U; Grobholz, R; Zentgraf, H
      Fas ligand expression in Hodgkin lymphoma

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    19. Watzlik, A; Dufter, C; Jung, M; Opelz, G; Terness, P
      Generation of FasL-expressing antigen-presenting cells for suppression of alloreactive T cells in the rat

      TRANSPLANTATION PROCEEDINGS
    20. Xu, B; Sakkas, LI; Slachta, CA; Goldman, BI; Jeevanandam, V; Oleszak, EL; Platsoucas, CD
      Apoptosis in chronic rejection of human cardiac allografts

      TRANSPLANTATION
    21. Li, XK; Fujino, M; Sugioka, A; Morita, M; Okuyama, T; Guo, L; Funeshima, N; Kimura, H; Enosawa, S; Amemiya, H; Suzuki, S
      Fulminant hepatitis by Fas-ligand expression in MRL-lpr/lpr mice grafted with Fas-positive livers and wild-type mice with Fas-mutant livers

      TRANSPLANTATION
    22. D'Alessio, A; Riccioli, A; Lauretti, P; Padula, F; Muciaccia, B; De Cesaris, P; Filippini, A; Nagata, S; Ziparo, E
      Testicular FasL is expressed by sperm cells

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    23. Anastassiou, G; Coupland, SE; Stang, A; Boeloeni, R; Schilling, H; Bornfeld, N
      Expression of Fas and Fas ligand in uveal melanoma: biological implicationand prognostic value

      JOURNAL OF PATHOLOGY
    24. Hohlbaum, AM; Gregory, MS; Ju, ST; Marshak-Rothstein, A
      Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors

      JOURNAL OF IMMUNOLOGY
    25. Dzialo-Hatton, R; Milbrandt, J; Hockett, RD; Weaver, CT
      Differential expression of Fas ligand in Th1 and Th2 cells is regulated byearly growth response gene and NF-AT family members

      JOURNAL OF IMMUNOLOGY
    26. Sata, M; Luo, ZY; Walsh, K
      Fas ligand overexpression on allograft endothelium inhibits inflammatory cell infiltration and transplant-associated intimal hyperplasia

      JOURNAL OF IMMUNOLOGY
    27. Jodo, S; Xiao, S; Hohlbaum, A; Strehlow, D; Marshak-Rothstein, A; Ju, ST
      Apoptosis-inducing membrane vesicles - A novel agent with unique properties

      JOURNAL OF BIOLOGICAL CHEMISTRY
    28. Cefai, D; Favre, L; Wattendorf, E; Marti, A; Jaggi, R; Gimmi, CD
      Role of Fas ligand expression in promoting escape from immune rejection ina spontaneous tumor model

      INTERNATIONAL JOURNAL OF CANCER
    29. Poulaki, V; Mitsiades, N; Mastorakos, G; Caspi, RR; Chrousos, GP; Bouzas, E
      Fas/Fas Ligand-associated apoptosis in experimental autoimmune uveoretinitis in rodents: Role of proinflammatory corticotropin-releasing hormone

      EXPERIMENTAL EYE RESEARCH
    30. Salih, HR; Starling, GC; Knauff, M; Llewellyn, MB; Davis, PM; Pitts, WJ; Aruffo, A; Kiener, PA
      Retinoic acid and vitamin E modulate expression and release of CD178 in carcinoma cells: Consequences for induction of apoptosis in CD95-sensitive cells

      EXPERIMENTAL CELL RESEARCH
    31. Shudo, K; Kinoshita, K; Imamura, R; Fan, H; Hasumoto, K; Tanaka, M; Nagata, S; Suda, T
      The membrane-bound but not the soluble form of human Fas ligand is responsible for its inflammatory activity

      EUROPEAN JOURNAL OF IMMUNOLOGY
    32. Fei, G; Peng, W; Chen, XL; Hu, ZY; Liu, YX
      Apoptosis occurs in implantation site of the rhesus monkey during early stage of pregnancy

      CONTRACEPTION
    33. Parr, TB; Hofman, FM; Kiener, PA; Stohl, W
      Cell cycle phase-specific survival of CD95 ligand-challenged Jurkat cells:Upregulation of heat-shock response

      CELLULAR IMMUNOLOGY
    34. Shimizu, M; Fontana, A; Takeda, Y; Yoshimoto, T; Tsubura, A; Matsuzawa, A
      Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilicpolymorphonuclear leukocytes associated with antitumor immunity

      CELLULAR IMMUNOLOGY
    35. Manos, EJ; Jones, DA
      Assessment of tumor necrosis factor receptor and fas signaling pathways bytranscriptional profiling

      CANCER RESEARCH
    36. Song, E; Chen, J; Ouyang, N; Su, F; Wang, M; Heemann, U
      Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer

      BRITISH JOURNAL OF CANCER
    37. Matsue, H; Matsue, K; Kusuhara, M; Kumamoto, T; Okumura, K; Yagita, H; Takashima, A
      Immunosuppressive properties of CD95L-transduced "killer" hybrids created by fusing donor- and recipient-derived dendritic cells

      BLOOD
    38. Hyer, ML; Voelkel-Johnson, C; Rubinchik, S; Dong, J; Norris, JS
      Intracellular Fas ligand expression causes Fas-mediated apoptosis in humanprostate cancer cells resistant to monoclonal antibody-induced apoptosis

      MOLECULAR THERAPY
    39. Allison, J
      Transgenic mouse models of islet beta cell death

      IMMUNOLOGIST
    40. Sata, M; Suhara, T; Walsh, K
      Vascular endothelial cells and smooth muscle cells differ in expression ofFas and Fas ligand and in sensitivity to Fas ligand-induced cell death - Implications for vascular disease and therapy

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    41. Schaub, FJ; Han, DKM; Liles, WC; Adams, LD; Coats, SA; Ramachandran, RK; Seifert, RA; Schwartz, SM; Bowen-Pope, DF
      Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells

      NATURE MEDICINE
    42. Restifo, NP
      Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape

      NATURE MEDICINE
    43. Ferreira, CG; Tolis, C; Span, SW; Peters, GJ; van Lopik, T; Kummer, AJ; Pinedo, HM; Giaccone, G
      Drug-induced apoptosis in lung cancer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway

      CLINICAL CANCER RESEARCH
    44. Lorz, C; Ortiz, A; Justo, P; Gonzalez-Cuadrado, S; Duque, N; Gomez-Guerrero, C; Egido, J
      Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    45. Bruder, JT; Appiah, A; Kirkman, WM; Chen, P; Tian, J; Reddy, D; Brough, DE; Lizonova, A; Kovesdi, I
      Improved production of adenovirus vectors expressing apoptotic transgenes

      HUMAN GENE THERAPY
    46. Gochuico, BR; Zhang, J; Ma, BY; Marshak-Rothstein, A; Fine, A
      TRAIL expression in vascular smooth muscle

      AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
    47. Schmidt, F; Groscurth, P; Dichgans, J; Weller, M
      Human malignant glioma cell lines are refractory to retinoic acid-mediateddifferentiation and sensitization to apoptosis

      CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
    48. Roth, W; Grimmel, C; Rieger, L; Strik, H; Takayama, S; Krajewski, S; Meyermann, R; Dichgans, J; Reed, JC; Weller, M
      Bag-1 and Bcl-2 gene transfer in malignant glioma: Modulation of cell cycle regulation and apoptosis

      BRAIN PATHOLOGY
    49. Li, Y; McCormack, AM; Brand, NJ; Yacoub, MH
      A strategy for inducing immune tolerance to valve endothelial cells through gene transfer

      JOURNAL OF HEART VALVE DISEASE
    50. Muller, S; van den Boom, D; Zirkel, D; Koster, H; Berthold, F; Schwab, M; Westphal, M; Zumkeller, W
      Retention of imprinting of the human apoptosis-related gene TSSC3 in humanbrain tumors

      HUMAN MOLECULAR GENETICS
    51. Mor, G; Kohen, F; Garcia-Velasco, J; Nilsen, J; Brown, W; Song, J; Naftolin, F
      Regulation of Fas ligand expression in breast cancer cells by estrogen: functional differences between estradiol and tamoxifen

      JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
    52. Kawasaki, M; Kuwano, K; Nakanishi, Y; Hagimoto, N; Takayama, K; Pei, XH; Maeyama, T; Yoshimi, M; Hara, N
      Analysis of Fas and Fas ligand expression and function in lung cancer celllines

      EUROPEAN JOURNAL OF CANCER
    53. Thellin, O; Coumans, B; Zorzi, W; Igout, A; Heinen, E
      Tolerance to the foeto-placental 'graft': ten ways to support a child for nine months

      CURRENT OPINION IN IMMUNOLOGY
    54. Roth, W; Wild-Bode, C; Platten, M; Grimmel, C; Melkonyan, HS; Dichgans, J; Weller, M
      Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells

      ONCOGENE
    55. Shinoura, N; Yoshida, Y; Asai, A; Kirino, T; Hamada, H
      Adenovirus-mediated transfer of p53 and Fas ligand drastically enhances apoptosis in gliomas

      CANCER GENE THERAPY
    56. Nakajima, A; Hirai, H; Kayagaki, N; Yoshino, S; Hirose, S; Yagita, H; Okumura, K
      Treatment of lupus in NZB/W F1 mice with monoclonal antibody against Fas ligand

      JOURNAL OF AUTOIMMUNITY
    57. Wohlleben, G; Ibrahim, SM; Schmidt, J; Toyka, KV; Hartung, HP; Gold, R
      Regulation of Fas and FasL expression on rat Schwann cells

      GLIA
    58. Zavazava, N; Kabelitz, D
      Alloreactivity and apoptosis in graft rejection and transplantation tolerance

      JOURNAL OF LEUKOCYTE BIOLOGY
    59. Streilein, JW; Stein-Streilein, J
      Does innate immune privilege exist?

      JOURNAL OF LEUKOCYTE BIOLOGY
    60. Emmenegger, U; Zehnder, R; Frey, U; Reimers, A; Spaeth, P; Neftel, KA
      Elevation of soluble Fas and soluble Fas ligand in reactive macrophage activation syndromes

      AMERICAN JOURNAL OF HEMATOLOGY
    61. Ferrer, I; Blanco, R; Cutillas, B; Ambrosio, S
      Fas and Fas-L expression in Huntington's disease and Parkinson's disease

      NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    62. Zipp, F
      Apoptosis in multiple sclerosis

      CELL AND TISSUE RESEARCH
    63. Re, D; Hofmann, A; Wolf, J; Diehl, V; Staratschek-Jox, A
      Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95 (vol 28, pg 31, 2000)

      EXPERIMENTAL HEMATOLOGY
    64. Re, D; Hofmann, A; Wolf, J; Diehl, V; Staratschek-Jox, A
      Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95

      EXPERIMENTAL HEMATOLOGY
    65. Hori, J; Streilein, JW
      Corneal endothelium confers immune privilege on the cornea as an allograft

      CORNEA
    66. Sotozono, C; Sano, Y; Suzuki, T; Tada, R; Ikeda, T; Nagata, S; Kinoshita, S
      Soluble Fas ligand expression in the ocular fluids of uveitis patients

      CURRENT EYE RESEARCH
    67. Pinkoski, MJ; Brunner, T; Green, DR; Lin, T
      Fas and Fas ligand in gut and liver

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    68. Bossi, G; Stinchcombe, JC; Page, LJ; Griffiths, GM
      Sorting out the multiple roles of Fas ligand

      EUROPEAN JOURNAL OF CELL BIOLOGY
    69. Yi, FH; Lautrette, C; Vermot-Desroches, C; Bordessoule, D; Couratier, P; Wijdenes, J; Preud'homme, JL; Jauberteau, MO
      In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients

      JOURNAL OF NEUROIMMUNOLOGY
    70. Hammer, A; Dohr, G
      Expression of Fas-ligand in first trimester and term human placental villi

      JOURNAL OF REPRODUCTIVE IMMUNOLOGY
    71. Kawaguchi, S; Mineta, T; Ichinose, M; Masuoka, J; Shiraishi, T; Tabuchi, K
      Induction of apoptosis in glioma cells by recombinant human Fas ligand

      NEUROSURGERY
    72. Hori, J; Joyce, N; Streilein, JW
      Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    73. Wenkel, H; Streilein, JW
      Evidence that retinal pigment epithelium functions as an immune-privilegedtissue

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    74. Treon, SP; Raje, N; Anderson, KC
      Immunotherapeutic strategies for the treatment of plasma cell malignancies

      SEMINARS IN ONCOLOGY
    75. van den Brink, MRM; Moore, E; Horndasch, KJ; Crawford, JM; Murphy, GF; Burakoff, SJ
      Fas ligand-deficient gld mice are more susceptible to graft-versus-host-disease

      TRANSPLANTATION
    76. Kang, SM; Braat, D; Schneider, DB; O'Rourke, RW; Lin, ZH; Ascher, NL; Dichek, DA; Baekkeskov, S; Stock, PG
      A non-cleavable mutant of Fas ligand does not prevent neutrophilic destruction of islet transplants

      TRANSPLANTATION
    77. Turvey, SE; Gonzalez-Nicolini, V; Kingsley, CI; Larregina, AT; Morris, PJ; Castro, MG; Lowenstein, PR; Wood, KJ
      Fas ligand-transfected myoblasts and islet cell transplantation

      TRANSPLANTATION
    78. Honey, K; Cobbold, SP; Waldmann, H
      Dominant tolerance and linked suppression induced by therapeutic antibodies do not depend on Fas-FasL interactions

      TRANSPLANTATION
    79. Kimmel, SG; Ohbatake, M; Kushida, M; Merguerian, P; Clarke, ID; Kim, PCW
      Murine xenogeneic immune responses to the human testis: A presumed immune-privileged tissue

      TRANSPLANTATION
    80. Wagener, ME; Konieczny, BT; Dai, ZH; Ring, GH; Lakkis, FG
      Alloantigen-driven T cell death mediated by Fas ligand and tumor necrosis factor-alpha is not essential for the induction of allograft acceptance

      TRANSPLANTATION
    81. Balkundi, DR; Hanna, N; Hleb, M; Dougherty, J; Sharma, S
      Labor-associated changes in Fas ligand expression and function in human placenta

      PEDIATRIC RESEARCH
    82. Basolo, F; Fiore, L; Baldanzi, A; Giannini, R; Dell'Omodarme, M; Fontanini, G; Pacini, F; Danesi, R; Miccoli, P; Toniolo, A
      Suppression of Fas expression and down-regulation of Fas ligand in highly aggressive human thyroid carcinoma

      LABORATORY INVESTIGATION
    83. Schaefer, JT; Barthlen, W; Schweizer, P
      Ceramide induces apoptosis in neuroblastoma cell cultures resistant to CD95 (Fas/APO-1)-mediated apoptosis

      JOURNAL OF PEDIATRIC SURGERY
    84. Takamizawa, S; Okamoto, S; Wen, J; Bishop, W; Kimura, K; Sandler, A
      Overexpression of fas-ligand by neuroblastoma: A novel mechanism of tumor-cell killing

      JOURNAL OF PEDIATRIC SURGERY
    85. Yakirevich, E; Maroun, L; Cohen, O; Izhak, OB; Rennert, G; Resnick, MB
      Apoptosis, proliferation, and Fas (APO-I, CD95)/Fas ligand expression in medullary carcinoma of the breast

      JOURNAL OF PATHOLOGY
    86. Roskams, T; Libbrecht, L; Van Damme, B; Desmet, V
      Fas and Fas ligand: strong co-expression in human hepatocytes surrounding hepatocellular carcinoma; can cancer induce suicide in peritumoural cells?

      JOURNAL OF PATHOLOGY
    87. Mullauer, L; Mosberger, I; Grusch, M; Rudas, M; Chott, A
      Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer

      JOURNAL OF PATHOLOGY
    88. Saitoh, A; Kawanabe, T; He, WD; Kayagaki, N; Kawamura, T; Yagita, H; Okumura, K; Shimada, S
      Selective upregulation of fibroblast fas ligand expression, and prolongation of Fas/Fas ligand-mediated skin allograft survival, by retinoic acid: The skin as a retinoide-inducible immune privilege site

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    89. Mueller, CM; Scott, DW
      Distinct molecular mechanisms of Fas resistance in murine B lymphoma cells

      JOURNAL OF IMMUNOLOGY
    90. Delgado, M; Ganea, D
      Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit T cell-mediated cytotoxicity by inhibiting fas ligand expression

      JOURNAL OF IMMUNOLOGY
    91. Hohlbaum, AM; Moe, S; Marshak-Rothstein, A
      Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival

      JOURNAL OF EXPERIMENTAL MEDICINE
    92. Song, J; Sapi, E; Brown, W; Nilsen, J; Tartaro, K; Kacinski, BM; Craft, J; Naftolin, F; Mor, G
      Roles of Fas and Fas ligand during mammary gland remodeling

      JOURNAL OF CLINICAL INVESTIGATION
    93. Nelson, DP; Setser, E; Hall, DG; Schwartz, SM; Hewitt, T; Klevitsky, R; Osinska, H; Bellgrau, D; Duke, RC; Robbins, J
      Proinflammatory consequences of transgenic Fas ligand expression in the heart

      JOURNAL OF CLINICAL INVESTIGATION
    94. Igney, FH; Behrens, CK; Krammer, PH
      Tumor counterattack - concept and reality

      EUROPEAN JOURNAL OF IMMUNOLOGY
    95. Li-Weber, M; Laur, O; Dern, K; Krammer, PH
      T cell activation-induced and HIV Tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappa B

      EUROPEAN JOURNAL OF IMMUNOLOGY
    96. Korbutt, GS; Suarez-Pinzon, WL; Power, RF; Rajotte, RV; Rabinovitch, A
      Testicular Sertoli cells exert both protective and destructive effects on syngeneic islet grafts in non-obese diabetic mice

      DIABETOLOGIA
    97. Suarez-Pinzon, W; Korbutt, GS; Power, R; Hooton, J; Rajotte, RV; Rabinovitch, A
      Testicular Sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta 1-dependent mechanism

      DIABETES
    98. Sasaki, Y; Ami, Y; Nakasone, T; Shinohara, K; Takahashi, E; Ando, S; Someya, K; Suzaki, Y; Honda, M
      Induction of CD95 ligand expression on T lymphocytes and B lymphocytes andits contribution to apoptosis of CD95-up-regulated CD4(+) T lymphocytes inmacaques by infection with a pathogenic simian/human immunodeficiency virus

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    99. Jeremias, I; Kupatt, C; Martin-Villalba, A; Habazettl, H; Schenkel, J; Boekstegers, P; Debatin, KM
      Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia

      CIRCULATION
    100. Stohl, W; Xu, D; Starling, GC; Casali, P; Kiener, PA
      Promotion of activated human B cell apoptosis and inhibition of Ig production by soluble CD95 ligand: CD95-based downregulation of Ig production neednot culminate in activated B cell death

      CELLULAR IMMUNOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 13/08/20 alle ore 02:44:45